The MEA dietary supplements market is expected to grow from US$ 9,551.77 million in 2021 to US$ 14,646.02 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028.
In recent years, the market has experienced various technological advancements. For instance, traditional hard and soft gelatin capsules, lozenges, tablets, powders, and liquids are joined by several other types of supplement forms, such as gummies, bilayer tablets, or granules. Due to increased product innovation and rising consumer desire for personalization in the supplement sector, consumers now have access to a diverse selection of delivery forms to suit their specific lifestyles and preferences, providing the industry with the option to solve swallowing issues and cater to increased consumer demand for customization. As a result, manufacturers are focusing on innovations and are launching new products in different forms and flavors. Furthermore, in April 2019, Amway introduced a new probiotic supplement named Nutrilite Balance Within. This product is a dietary supplement that helps the human body with clinically established probiotic levels for gut and immunological health. Due to these trends and factors, the MEA dietary supplements market is expected to witness new opportunities for growth in the near future.
In the MEA region, Turkey, South Africa, Iraq, and Israel are among the major countries with a high number of COVID-19 confirmed cases and deaths. According to the International Finance Corporation, the COVID-19 pandemic has a severe impact on the economy of the MEA which has led to declining oil production, tourism, and remittances. The quarantine measures implemented for sanitary purposes in the region have led to a standstill of several activities across diverse economic sectors. The MEA region comprises many growing economies, which are prospective markets for dietary supplements vendors. The pandemic has significantly increased the growth of the dietary supplements market in the region due to various health benefits associated with it and it also helps in improving the immune system against COVID-19.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA dietary supplements market. The MEA dietary supplements market is expected to grow at a good CAGR during the forecast period.
MEA Dietary Supplements Market Revenue and Forecast to 2028 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
MEA Dietary Supplements Market Segmentation
MEA Dietary Supplements Market – By Type
- Vitamins
- Minerals
- Proteins and Amino Acids
- Probiotics
- Blends
- Others
MEA Dietary Supplements Market – By Form
- Tablets
- Capsules and Softgels
- Powders
- Others
MEA Dietary Supplements Market – By Distribution Channel
- Supermarkets and Hypermarkets
- Specialty Stores
- Online Retail
- Others
MEA Dietary Supplements Market, by Country
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
MEA Dietary Supplements Market - Companies Mentioned
- Abbott
- Amway Corp.
- Bayer AG
- Bionova
- GlaxoSmithKline plc.
- Otsuka Holdings Co., Ltd
- Pfizer Inc.
- The Bountiful Compan
Middle East and Africa Dietary Supplements Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 9,551.77 Million |
Market Size by 2028 | US$ 14,646.02 Million |
Global CAGR (2021 - 2028) | 6.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- Hair Wig Market
- Oxy-fuel Combustion Technology Market
- Medical Devices Market
- Electronic Signature Software Market
- Mobile Phone Insurance Market
- Queue Management System Market
- Smart Parking Market
- Pharmacovigilance and Drug Safety Software Market
- Enzymatic DNA Synthesis Market
- Third Party Logistics Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Consumer Goods : READ MORE..
- Abbott
- Amway Corp.
- Bayer AG
- Bionova
- GlaxoSmithKline plc.
- Otsuka Holdings Co., Ltd
- Pfizer Inc.
- The Bountiful Company